pbs_code
stringlengths
5
6
drug
stringclasses
15 values
brand
stringclasses
28 values
formulation
stringclasses
35 values
indication
stringclasses
7 values
treatment_phase
stringclasses
53 values
streamlined_code
stringclasses
33 values
online_application
bool
2 classes
authority_method
stringclasses
2 values
hospital_type
stringclasses
3 values
schedule_code
int64
4.35k
4.35k
schedule_year
int64
2.02k
2.02k
schedule_month
stringclasses
1 value
12425Y
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12425Y
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled pen
juvenile idiopathic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13308K
etanercept
Enbrel
Injections 50 mg in 1 mL single use pre-filled syringes, 4
juvenile idiopathic arthritis
Continuing treatment
14154
true
STREAMLINED
Public
4,354
2,024
OCTOBER
3428K
golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled syringe
rheumatoid arthritis
First continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
3428K
golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled syringe
rheumatoid arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12442W
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
11486M
infliximab
Renflexis
Powder for I.V. infusion 100 mg
ankylosing spondylitis
First continuing treatment
14683
true
STREAMLINED
Public
4,354
2,024
OCTOBER
11486M
infliximab
Inflectra
Powder for I.V. infusion 100 mg
ankylosing spondylitis
First continuing treatment
14683
true
STREAMLINED
Public
4,354
2,024
OCTOBER
11486M
infliximab
Renflexis
Powder for I.V. infusion 100 mg
ankylosing spondylitis
Subsequent continuing treatment
14701
true
STREAMLINED
Public
4,354
2,024
OCTOBER
11486M
infliximab
Inflectra
Powder for I.V. infusion 100 mg
ankylosing spondylitis
Subsequent continuing treatment
14701
true
STREAMLINED
Public
4,354
2,024
OCTOBER
13727L
abatacept
Orencia ClickJect
Injection 125 mg in 1 mL single dose autoinjector
rheumatoid arthritis
Subsequent continuing treatment
14604
true
STREAMLINED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
9033K
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
8737W
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Humira
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12378L
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12329X
adalimumab
Hadlima
Injection 40 mg in 0.8 mL pre-filled pen
rheumatoid arthritis
Subsequent continuing treatment
14499
true
STREAMLINED
Any
4,354
2,024
OCTOBER
12329X
adalimumab
Abrilada
Injection 40 mg in 0.8 mL pre-filled pen
rheumatoid arthritis
Subsequent continuing treatment
14499
true
STREAMLINED
Any
4,354
2,024
OCTOBER
12329X
adalimumab
Amgevita
Injection 40 mg in 0.8 mL pre-filled pen
rheumatoid arthritis
Subsequent continuing treatment
14499
true
STREAMLINED
Any
4,354
2,024
OCTOBER
12329X
adalimumab
Hyrimoz
Injection 40 mg in 0.8 mL pre-filled pen
rheumatoid arthritis
Subsequent continuing treatment
14499
true
STREAMLINED
Any
4,354
2,024
OCTOBER
12576X
infliximab
Remsima SC
Solution for injection 120 mg in 1 mL pre-filled syringe
rheumatoid arthritis
Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13690M
tocilizumab
Actemra
Concentrate for injection 80 mg in 4 mL
rheumatoid arthritis
Subsequent continuing treatment
14621
true
STREAMLINED
Public
4,354
2,024
OCTOBER
13763J
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Yuflyma
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Adalicip
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
13763J
adalimumab
Hadlima
Injection 40 mg in 0.4 mL pre-filled syringe
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
true
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER
12554R
infliximab
Remsima SC
Solution for injection 120 mg in 1 mL pre-filled pen
rheumatoid arthritis
Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form
null
false
AUTHORITY_REQUIRED
Any
4,354
2,024
OCTOBER